logo.jpg.jpg
ViaDerma Update on Stability Testing, Global Sales Distribution, National Licensing, Nupelo & More
24 oct. 2023 10h30 HE | ViaDerma, Inc.
LOS ANGELES, Calif., Oct. 24, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM) is pleased to announce several new and exciting business updates for current and prospective shareholders,...
logo.jpg.jpg
ViaDerma Announces Updates for Vitastem Global Sales Expansion, Nupelo FDA-Registration Status & More 
06 juil. 2023 08h00 HE | ViaDerma, Inc.
LOS ANGELES, July 06, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM) is very pleased to announce several exciting business updates for current and prospective shareholders, partners, and...
logo.jpg.jpg
ViaDerma Announces FDA Registration Application Update & Brand Name for New Hair Regrowth Product
16 mars 2023 08h00 HE | ViaDerma, Inc.
LOS ANGELES, March 16, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM) is pleased to announce that the company has recently submitted their application for their planned minoxidil hair...
logo.jpg.jpg
ViaDerma Announces Intent to Launch a New Minoxidil Hair Regrowth Product
08 mars 2023 08h00 HE | ViaDerma, Inc.
LOS ANGELES, March 08, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM) is pleased to announce their plans to launch a new hair regrowth product using Minoxidil (topical route). The company...
logo.jpg.jpg
ViaDerma Provides an Update on Current & Future Business Activities
02 mars 2023 08h00 HE | ViaDerma, Inc.
LOS ANGELES, March 02, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM) is pleased to provide an update on current business activities. ViaDerma has expanded its licensing agreement with a...
TIP_link_300x300.jpg
$13.24 Bn, Advanced Wound Care Market Share to Cross 4.6% CAGR by 2028 – Global Report by The Insight Partners
20 févr. 2023 07h56 HE | The Insight Partners
New York, Feb. 20, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Advanced Wound Care Market Size, Share, Growth, Trends and Global Forecasts to 2028 - Global Analysis and Forecasts by...
logo.jpg.jpg
ViaDerma Engages Intent Sciences to Power Up Digital Marketing & Brand Development
12 janv. 2023 08h00 HE | ViaDerma, Inc.
LOS ANGELES, Jan. 12, 2023 (GLOBE NEWSWIRE) --  ViaDerma, Inc., (OTC Pink: VDRM) is pleased to announce that they have engaged the growth marketing services of INTENT SCIENCES who will help grow the...
logo.jpg.jpg
ViaDerma Successfully Completes Quality Control Testing of its New Vitastem Products
15 sept. 2022 05h00 HE | ViaDerma, Inc.
LOS ANGELES, Sept. 15, 2022 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM) announces the successful completion of its internal quality control testing for their new Vitastem...
logo.jpg.jpg
ViaDerma Announces the Implementation of Internal Quality Control Measures for its New Vitastem Products
22 juin 2022 09h00 HE | ViaDerma, Inc.
LOS ANGELES, June 22, 2022 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM) announces plans to conduct additional internal quality control testing for their new Vitastem products....
logo.jpg.jpg
ViaDerma's 2021 Annual Report Shows Strong Revenue Growth Over the Previous Year
31 mars 2022 05h00 HE | ViaDerma, Inc.
LOS ANGELES, March 31, 2022 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM) announces the release of its 2021 Annual Report on the OTC Markets. The Company ended the year with...